Trinity Life Sciences Launches New Omnichannel Reporting Suite for Enhanced Marketing Insights Trinity Life Sciences, a leader in strategy, insights, and analytics for the life sciences sector, has unveiled an…
Ferring Pharmaceuticals Showcases Commitment to Advancing Fertility Care at 2024 ASRM Congress Ferring Pharmaceuticals will present new data from four abstracts at the 2024 American Society for Reproductive Medicine (ASRM)…
Successful Cyclotron Irradiation of Ra-226 Paves the Way for Actineer’s Large-Scale Ac-225 Production for Cancer Treatments Actineer, the joint venture between ITM and Canadian Nuclear Laboratories (CNL) Ltd., has achieved…
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced that five of its abstracts have been accepted for e-Poster presentations at the 2024 Annual Scientific Meeting of the American College of Allergy,…
Nordic Pharma, a subsidiary of Nordic Group BV, is advancing the U.S. introduction of LACRIFILL® Canalicular Gel, a novel therapy for dry eye, during the 2024 American Academy of Ophthalmology…
Celltrion has announced two-year findings from a post-hoc analysis of the LIBERTY studies (LIBERTY-CD and LIBERTY-UC), presented at United European Gastroenterology (UEG) Week 2024 in Vienna. The analysis shows that…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has shared positive results from its Phase 2b/3 clinical trial (MK-1654-004) evaluating clesrovimab, an investigational monoclonal antibody designed to…
Medidata, a Dassault Systèmes brand and a leader in clinical trial solutions for the life sciences industry, has launched Medidata Rave Lite, an extension of its flagship clinical research software,…
Xaira Therapeutics Appoints Dr. Debbie Law as Chief Scientific Officer and Julia Tran as Chief People Officer Xaira Therapeutics, an integrated biotechnology firm focused on leveraging AI to transform drug…
SullivanCotter Reports on Rising Healthcare Executive Compensation Amid Talent Competition SullivanCotter, a leading consulting firm specializing in total rewards programs and workforce solutions for healthcare, has published its 2024 Health…
Alnylam Pharmaceuticals, Inc. has submitted a Type II variation application to the European Medicines Agency (EMA) for vutrisiran, an investigational RNA interference (RNAi) therapy aimed at treating ATTR amyloidosis with…
Personalized Nutrition Market Report 2024: Overview and Growth Projections The report titled “Personalized Nutrition Market – Types, Forms, Applications and End-Use Markets” has been released by ResearchAndMarkets.com. The global personalized…